|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,096 GBX | -0.12% |
|
-1.80% | +14.11% |
| 08:09am | AstraZeneca aims to deliver $80 billion in total revenue by 2030 | RE |
| May. 20 | European Equities Close Higher in Monday Trading; Ryanair May Have to Lower Ticket Prices | MT |
(Reuters) - AstraZeneca said on Monday it will acquire U.S.-based clinical-stage biopharmaceutical company CinCor Pharma Inc in a deal valued at about $1.8 billion.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Savio D'Souza)
| 1st Jan change | Capi. | |
|---|---|---|
| +14.11% | 238B | |
| +34.35% | 705B | |
| +29.39% | 583B | |
| -3.49% | 364B | |
| +20.15% | 332B | |
| +6.19% | 291B | |
| -3.03% | 210B | |
| +10.02% | 209B | |
| +9.21% | 169B | |
| -0.90% | 162B |
ASTRAZENECA PLC 
